GlassScriptPhysician profile
Danielle J Miller
NPI 1013174531
$425.19
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $190 · 2023: $44.47 · 2024: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $125.00 | 2022 | |
| Intuitive Surgical, INC. | $50.87 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $46.04 | 2024 | Farxiga, Airsupra, Breztri |
| Mayne Pharma Commercial LLC | $43.43 | 2023-2024 | |
| Phathom Pharmaceuticals, INC. | $43.05 | 2024 | Voquezna |
| Biotronik Nro, INC. | $33.42 | 2024 | Prospera |
| Acella Pharmaceuticals, LLC | $24.68 | 2024 | NP Thyroid 60 |
| Paratek Pharmaceuticals, INC. | $16.01 | 2024 | Nuzyra |
| Lilly USA, LLC | $14.88 | 2024 | |
| Dexcom, INC. | $14.02 | 2023 | Dexcom G6 Transmitter |
| Ascensia Diabetes Care US INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.